Hamster preproglucagon contains the sequence of glucagon and two related peptides
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Glucagon is a 29-amino acid polypeptide hormone synthesized by the A cells of the endocrine pancreas. Its primary site of action is the liver where it stimulates glycogenolysis, gluconeogenesis and ketogenesis. In mammals, biosynthetic studies have shown that glucagon is derived from a precursor of molecular weight (Mr) approximately 18,000 which is five to six times larger than glucagon. Glucagon-containing polypeptides and immunoreactants of various sizes have also been described from stomach, intestine, brain and salivary gland. Here, we have determined the structure of hamster pancreatic preproglucagon from the sequence of its cDNA. This 180-amino acid precursor contains the sequence of glucagon and two glucagon-like polypeptides arranged in tandem. The precursor also contains the sequences of several non-pancreatic glucagon-containing polypeptides which suggests that, in mammals, both pancreatic and non-pancreatic glucagon and glucagon-containing polypeptides may be derived from a common precursor by tissue-specific processing. We have tentatively identified each of the glucagon-like immunoreactants which have been described with respect to the sequence of proglucagon and have proposed a scheme for the processing of pancreatic proglucagon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In fact, GIP-driven weight loss is synergistically enhanced by adjunct GLP-1R agonism47-49”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“This highlighted for the first time that supplemental GLP-1R/GIPR co-agonism could greatly outperform GLP-1R mono-agonism, to achieve greater weight loss and elicit further improvements in glucose homeostasis48.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“GIPR agonist treatment is equally effective in promoting weight loss in obese mice”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“MAR709 successfully completed Phase 1 clinical trials with good tolerability48,124,125, concomitant with a meaningful reduction in body weight and HbA1c levels in subjects with T2D48,125.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
In the citing paper
“There are two notable unimolecular GLP-1R/GIPR co-agonist peptides that have been preclinically and clinically most characterized to display enhanced glucose-lowering potential, superior weight loss and appetite suppression, when evaluated with comparable GLP-1R agonists.”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [48]
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Atlas of protein sequence and structure
Chang, M.-Y., Dayhoff, M. O., Eck, R. V., & Sochard, M. R. (1965) · NASA Technical Reports Server (NASA) · Cited by 4,383
3′ Non-coding region sequences in eukaryotic messenger RNA
Proudfoot, N. J., & Brownlee, G. G. (1976) · Nature · doi:10.1038/263211a0 · Cited by 2,968
Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis
Beaucage, S. L., & Caruthers, M. H. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)90461-7 · Cited by 1,993
Atlas of Protein Sequence and Structure, 1966.
Hersh, R. T., Eck, R. V., & Dayhoff, M. O. (1967) · Systematic Zoology · doi:10.2307/2412074 · Cited by 1,779
Growth Hormone-Releasing Factor from a Human Pancreatic Tumor That Caused Acromegaly
Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., & Wehrenberg, W. B. (1982) · Science · doi:10.1126/science.6812220 · Cited by 1,294
The sequence 5′-AAUAAA-3′ forms part of the recognition site for polyadenylation of late SV40 mRNAs
Fitzgerald, M. (1981) · Cell · doi:10.1016/0092-8674(81)90521-3 · Cited by 776
Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA
Comb, M., Seeburg, P. H., Adelman, J., Eiden, L., & Herbert, E. (1982) · Nature · doi:10.1038/295663a0 · Cited by 679
Research works printed but not linked: 1
- Unger, R.H. & Orei, L. (eds) Glucagon. Physiology, Pathophysiology and Morphology of the Pancreatic A-Cell (Elsevier, New York, 1981).
Cited by
Items 401–500 of 645
Mudumbi, J. B. N., Ntwampe, S. K. O., Mekuto, L., Matsha, T. E., & Itoba-Tombo, E. F. (2018) · Environmental Monitoring and Assessment · doi:10.1007/s10661-018-6634-2 · Cited by 16
Perakakis, N., Kalra, B., Angelidi, A. M., Kumar, A., Gavrieli, A., Yannakoulia, M., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155157 · Cited by 12
Preproglucagon and Its Processing
BATAILLE, D. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_3 · Cited by 13
Immunohistochemistry ofβ-neoendorphin and dynorphin in the endocrine pancreas of rat and man
Cetin, Y. (1985) · Histochemistry · doi:10.1007/bf00684384 · Cited by 12
“Possibly, rat glucagon precursor substances in contrast to hamster and bovine preproglucagon ( Bell et al. 1983; Lopez et al. 1983) may contain sequence homologies with these opioid peptides.”
BackgroundFuruse, M., Bungo, T., Shimojo, M., Masuda, Y., Saito, N., Hasegawa, S., & Sugahara, K. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00798-7 · Cited by 13
Synthesis of Peptide Hormones using Recombinant DNA Techniques
Wengenmayer, F. (1983) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198308421 · Cited by 14
Lee, Y. C., Campos, R. V., & Drucker, D. J. (1993) · Endocrinology · doi:10.1210/endo.133.1.8319563 · Cited by 13
Generation of Diversity of Opioid Peptides
Herbert, E., Civelli, O., DOUGLASS, J. O., Martens, G. J. M., & Rosen, H. (1985) · Biochemical Actions of Hormones · doi:10.1016/b978-0-12-452812-3.50005-1 · Cited by 12
Alluri, A. A., Kurien, M. M., Pokar, N. P., Madarapu, A., Sadam, S., Puvvala, N., & Seetharaman, R. (2025) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2024-0193 · Cited by 13
The role of glucagon‑like peptide 1 in glucose homeostasis and in other aspects of human physiology
Franek, E., Gajos, G., Gumprecht, J., Kretowski, A. J., Zahorska‐Markiewicz, B., & Malecki, M. T. (2009) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.829 · Cited by 14
The Changing Concept of Gut Endocrinology
Rehfeld, J. F. (2017) · Endocrine development · doi:10.1159/000475728 · Cited by 11
Posttranslational Processing of Proglucagon and Postsecretory Fate of Proglucagon Products
Holst, J. J., �rskov, C., Hartmann, B., & Deacon, C. F. (1997) · Frontiers in diabetes · doi:10.1159/000194728 · Cited by 15
The Glucagon Gene and Its Expression
Philippé, J. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_2 · Cited by 11
Gastrointestinal peptides after bariatric surgery and appetite control: are they in tuning?
Doucet, É. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32830ab9c9 · Cited by 13
Internalization of glucagon-like peptide-1(7–36)amide in rat insulinoma cells
Göke, R., Richter, G., Göke, B., TRAUTMANN, M. E., & Arnold, R. (1989) · Research in Experimental Medicine · doi:10.1007/bf01852257 · Cited by 11
“Mammalian proglucagons contain, in addition to the amino acid sequence of glucagon, two structurally related peptides, termed glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) [1, 2 , 10, 16].”
BackgroundMendre, C., Dufour, M. N., Roux, S. L., Seyer, R., Guillou, L., Calas, B., & Guillon, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.21027 · Cited by 11
Andrews, P., Alai, M., & Cotter, R. J. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90514-3 · Cited by 11
Gewinnung von Peptidhormonen durch DNA‐Rekombination
Wengenmayer, F. (1983) · Angewandte Chemie · doi:10.1002/ange.19830951106 · Cited by 11
Oxyntomodulin - past, present and future
Holst, J. J., & ROSENKILDE, M. M. (2025) · Peptides · doi:10.1016/j.peptides.2025.171393 · Cited by 12
“3) With the discovery of the products of the C-terminal part of the glucagon precursor [35], namely GLP-1 and GLP-2, and the demonstration of the effects of GLP-1 on insulin secretion, acid secretion, and appetite and food intake, oxyntomodulin was somewhat overshadowed [36].”
Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits
Hwang, E., Portillo, B., & Williams, K. W. (2025) · Endocrinology · doi:10.1210/endocr/bqaf125 · Cited by 10
Lee, J., & Kim, W. K. (2023) · Animals · doi:10.3390/ani13182975 · Cited by 10
“Also, pre-proglucagon, a precursor of GLP, is converted to glucagon, glucagon-like peptide-1 (GLP-1), glucagon-like peptide-2 (GLP-2), and oxyntomodulin (OXM), depending on the sites of syntheses by prohormone convertase 1 and 2 [73].”
BackgroundImaging pancreatic islet cells by positron emission tomography
Li, J., Karunananthan, J., Pelham, B., & KANDEEL, F. R. (2016) · World Journal of Radiology · doi:10.4329/wjr.v8.i9.764 · Cited by 11
The apoptosis and GLP-1 hyposecretion induced by LPS via RIP/ROS/mTOR pathway in GLUTag cells
Wang, J., Wang, X., Li, Z., Guo, F., Ding, C., Zhao, Y., Liu, Y., Ma, X., Li, C. V., Wu, L., et al. (2019) · Biochimie · doi:10.1016/j.biochi.2019.04.001 · Cited by 10
Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans
Modrzynska, J., Klein, C. F., Iversen, K. K., Bundgaard, H., Hartmann, B., Mose, M., Rittig, N. F., Møller, N., Holst, J. J., & Albrechtsen, N. J. W. (2021) · Endocrine Connections · doi:10.1530/ec-20-0590 · Cited by 10
“1), and have opposite effects on glucose homeostasis (1-3).”
BackgroundLiraglutide: a human GLP-1 analog for Type 2 diabetes
Vilsbøll, T. (2009) · Therapy · doi:10.2217/14750708.6.2.199 · Cited by 10
Glucagon-like peptide-1 inhibits insulinotropic effects of oxyntomodulin and glucagon in cattle
ThanThan, S., Saito, T., Yannaing, S., Zhao, H., Nakashima, K., & Kuwayama, H. (2011) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2011.11.004 · Cited by 13
“[1] Bell GI, Santerre RF, Mullenbach GT.”
BackgroundEffect of intraluminal administration of amino acids upon plasma glicentin
Ohneda, A., Kobayashi, T., Nihei, J., & Takahashi, H. (1988) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(88)80061-5 · Cited by 10
GLP-1 analogs: satiety without malaise?
Tang‐Christensen, M., & Cowley, M. A. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00449.2007 · Cited by 11
“(1) discovered GLP-1 as a tissue-specific posttranslational product of preproglucagon primarily located in the L cells of the gut but also in the alpha cells of the pancreas and in brain stem neurons (7).”
BackgroundControl of Glucose Homeostasis by Incretin Hormones
Perfetti, R., Brown, T. A., Velikina, R., & Busselen, S. (1999) · Diabetes Technology & Therapeutics · doi:10.1089/152091599317215 · Cited by 12
Isolation and primary structure of glucagon from the endocrine pancreas of Thunnus obesus
Navarro, I., Gutiérrez, J., Caixach, J., Rivera, J., & Planas, J. V. (1991) · General and Comparative Endocrinology · doi:10.1016/0016-6480(91)90025-2 · Cited by 10
García‐Flores, M., Zueco, J. A., Álvarez, E., & Blázquez, E. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01865.x · Cited by 10
Sequence of a cDNA encoding Syrian hamster islet amyloid polypeptide precursor
Nishi, M., Bell, G. I., & Steiner, D. F. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.22.6726 · Cited by 10
Self-citationDiscovery of peptides as key regulators of metabolic and cardiovascular crosstalk
Zhang, Z., & Svensson, K. J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115836 · Cited by 10
Lasher, A. T., Srivastava, H. K., & Sun, L. Y. (2022) · Biomedicines · doi:10.3390/biomedicines10081907 · Cited by 10
“This 29 amino acid peptide is derived from the processing of proglucagon within the α-cells [2,3] by prohormone convertase 2 [4] and is subsequently secreted.”
BackgroundPeptide Signaling in Taste Transduction
Takai, S., Yoshida, R., Shigemura, N., & Ninomiya, Y. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801694-7.00017-2 · Cited by 10
Molecular pathophysiology of glucagon-SV40 T antigen transgenic mice
Drucker, D. J. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.5.e629 · Cited by 11
Therapeutic Strategies Exploiting DP IV Inhibition: Target disease: Type 2 Diabetes
Hoffmann, T., & Demuth, H. (2002) · Springer eBooks · doi:10.1007/978-1-4615-0619-5_10 · Cited by 9
Mommsen, T. P., & Plisetskaya, E. M. (1993) · Fish Physiology and Biochemistry · doi:10.1007/bf00004593 · Cited by 9
“In the last decade, GLPs have been found, located and characterized in pancreas, intestine and/or brain of most major groups of vertebrates, including lampreys (Cheung et al. 1991), elasmobranchs (Tagliafierro et al. 1989), holocephalans (Conlon et al. 1987), teleosts (Lund et al. 1983; Andrews and Ronner 1985; Pliset…”
BackgroundComparative Neuroendocrinology of Gut Peptides
Dockray, G. J. (1989) · Comprehensive physiology · doi:10.1002/cphy.cp060208 · Cited by 9
Alluri, A. A., Guntupalli, Y., Suvarna, S. S., Prystupa, Y., Khetan, S. P., Vejandla, B., & Swathi, N. L. (2025) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2025-0031 · Cited by 11
Can Bayliss and Starling gut hormones cure a worldwide pandemic?
Scott, R., Tan, T., & Bloom, S. R. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.272955 · Cited by 10
Incretins and Their Endocrine and Metabolic Functions
Seufert, J. (2017) · Endocrine development · doi:10.1159/000475730 · Cited by 9
DPP-4 inhibitor des-F-sitagliptin treatment increased insulin exocytosis from db/db mice β cells
Nagamatsu, S., Ohara‐Imaizumi, M., Nakamichi, Y., Aoyagi, K., & Nishiwaki, C. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.119 · Cited by 8
Isolation and amino acid sequences of squirrel monkey (Saimiri sciurea) insulin and glucagon.
Yu, J. H., Eng, J., & Yalow, R. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9766 · Cited by 8
N-acetyl oxyntomodulin30?37: pharmacokinetics and activity on gastric acid secretion
Carles-Bonnet, C., Jarrousse, C., Niel, H., Martínez, J., Rolland, M., & BATAILLE, D. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00175470 · Cited by 8
Recent developments in the chemistry of gastrointestinal peptides
Mutt, V. (1990) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1990.tb01770.x · Cited by 8
Cyclic-AMP-dependent phosphorylation of glicentin
Conlon, J. M., Thim, L., Moody, A. J., & Söling, H. (1984) · Bioscience Reports · doi:10.1007/bf01122224 · Cited by 8
Rhesus monkey gastroenteropancreatic hormones: relationship to human sequences
Yu, J., Xin, Y., Eng, J., & Yalow, R. S. (1991) · Regulatory Peptides · doi:10.1016/0167-0115(91)90005-2 · Cited by 9
GLUCAGON-LIKE PEPTIDE-1 IN THE RAT PANCREAS
Manaka, H., TANIGUCHI, H., WADA, K., Takahashi, H., Takahashi, K. A., Katagiri, T., & Sasaki, H. (1987) · Biomedical Research · doi:10.2220/biomedres.8.1 · Cited by 8
“For radioimmunoassay the antiserum was used at a final dilution of 1 :70,000 and cross-reacted equally with both GLP-1 [1-36 amide] and GLP-1 [1-37].”
BackgroundMethodInfluentialZhang, T., Liu, S., He, S., Shi, L., & Ma, R. (2025) · ChemBioChem · doi:10.1002/cbic.202400962 · Cited by 10
GLP-1 localisation and proglucagon gene expression in healthy and diabetic mouse ileum
TAŞÇI, S. K., & BİNGÖL, S. A. (2018) · Journal of Veterinary Research · doi:10.2478/jvetres-2018-0033 · Cited by 9
“For instance, proglucagon is cleaved to glucagon by PC2 in pancreatic α-cells but is cleaved to GLP-1 by PC1/3 in intestinal L cells (2, 13, 16, 27).”
BackgroundMicroscopic Anatomy of the Human Islet of Langerhans
Veld, P. I. '., & Smeets, S. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_1 · Cited by 10
Immunoreactive glucagons purified from dog pancreas, stomach and ileum
Shinomura, Y., Eng, J., & Yalow, R. S. (1988) · Regulatory Peptides · doi:10.1016/0167-0115(88)90230-3 · Cited by 8
Seeley, R. J., Woods, S. C., & D’Alessio, D. A. (2000) · Endocrinology · doi:10.1210/endo.141.2.7372 · Cited by 9
“The existence of GLP-1 was inferred from the cloning of a complementary DNA for preproglucagon, making it one of the first peptides discovered on the basis of a nucleic acid sequence (2, 3).”
BackgroundOntogeny of glucagon messenger RNA and encoded precursor in the rat intestine
Jin, S.-L. C., Hynes, M., & Lund, P. K. (1990) · Regulatory Peptides · doi:10.1016/0167-0115(90)90075-8 · Cited by 7
Shen, J., Wang, M., Pang, G., Zhang, Y., Zhang, J., Shi, Y., Liu, J., & Zhan, C. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00528.2024 · Cited by 7
Shirani, A., & Stüve, O. (2025) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2025.2587277 · Cited by 7
“Cloning of the glucagon gene later revealed that the proglucagon prohormone encoded not only pancreatic glucagon but also two novel gut peptides: GLP-1 and GLP-2 [8,9].”
Carpio, L. E., Olivares, M., Benítez‐Páez, A., Serrano‐Candelas, E., Barigye, S. J., Sanz, Y., & Gozalbes, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115744 · Cited by 5
“The role of GLP-1 in regulating glycemia was recognized in 1986, when it was found to have significant effects on the endocrine pancreas [24,25].”
BackgroundFukumura, K., Narimatsu, Y., Moriwaki, S., Ukena, K., Furumitsu, M., & Ukena, K. (2021) · Molecules · doi:10.3390/molecules26196006 · Cited by 6
“For instance, glucagon-like peptide-1, a 31-amino-acid hormone secreted from the lower intestine and colon, acts directly on the pancreatic islets to stimulate insulin secretion [48,49].”
BackgroundDragosics, B., Bauer, P., & Radaszkiewicz, T. (1985) · Cancer · doi:10.1002/1097-0142(19850301)55:5<1060::aid-cncr2820550523>3.0.co;2-8 · Cited by 279
Proglucagon expression, posttranslational processing and secretion in SV40-transformed islet cells
SHENNAN, K. I. J., Holst, J. J., & Docherty, K. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90234-7 · Cited by 6
Physiology and Pathophysiology of GLP-1
Göke, B., Göke, R., Fehmann, H. C., & Bode, H. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61150-6_17 · Cited by 6
Hara, M., Varndell, I. M., Bishop, A. E., Aitchison, M., Rode, J. W., Yamada, T., Green, D. M., Bloom, S. R., & Polak, J. M. (1987) · Molecular and Cellular Probes · doi:10.1016/0890-8508(87)90010-7 · Cited by 6
Nucleotide substitution type dependence of generation time effect of molecular evolution.
KISAKIBARU, Y., & Matsuda, H. (1995) · The Japanese Journal of Genetics · doi:10.1266/jjg.70.373 · Cited by 7
One gene, several messages. From multifunctional proteins to endogenous opiates
Fr�zal, J., Münnich, A., & Mitchell, G. A. (1983) · Human Genetics · doi:10.1007/bf00292362 · Cited by 6
“In addition, two genes are known which code for glucagon, and each contains two copies of the specific sequence for glucagon (Kolata 1982), and one hamster gene has been shown to contain the sequence of glucagon and two related peptides ( Bell et al. 1983 ).”
BackgroundUse of glucagon-like polypeptide 2 analogs for intestinal failure
Goldschmidt, M. L., Oliveira, S. B., Slaughter, C., & Kocoshis, S. A. (2024) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2024.2431291 · Cited by 5
“By 1983, hamster and human proglucagon and its component peptides were sequenced [3,4].”
Supramolecular oral delivery technologies for polypeptide-based drugs
Chen, J., Liu, T., Wang, M., Lü, B., Bai, D., Shang, J., Chen, Y., & Zhang, J. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.045 · Cited by 5
Tiwari, S., Kaur, P., Gupta, D., Chaudhury, S., Chaudhary, M., Mittal, A., Kumar, S., & Sahu, S. K. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230522112758 · Cited by 6
Gastrointestinal hormones: History, biology, and measurement
Rehfeld, J. F., & Goetze, J. P. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2023.11.004 · Cited by 6
Holst, J. J. (2024) · The Journal of Physiology · doi:10.1113/jp287461 · Cited by 5
The insulin centennial—100 years of milestones in biochemistry
Attie, A., Tang, Q.-Q., & Bornfeldt, K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101278 · Cited by 6
“He showed that the gene encoded glucagon, the incretin glucagon-like peptide-1 (GLP1) and glucagon-like peptide-2 (39).”
BackgroundKwon, O. (2021) · Stroke revisited · doi:10.1007/978-981-16-5123-6_1 · Cited by 8
Decrease in plasma GLP-1 immunoreactivity in starved rats
Takahashi, J., Noma, Y., Yoshimoto, S., Fujita, C., & Shima, K. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90026-n · Cited by 6
Oxytocin and Vasopressin Genes
Richter, D. (1987) · Humana Press eBooks · doi:10.1007/978-1-4612-4824-8_8 · Cited by 5
GLP‐1 C‐terminal structures affect its blood glucose lowering‐function
Li, Y., Shi, C., Lv, Q.-J., Zhang, H., Biehu, L., Bian, G., Huang, Q., Zhang, W., Xue, X., Ren, X., et al. (2008) · Journal of Peptide Science · doi:10.1002/psc.997 · Cited by 5
Lee, Y. C., & Drucker, D. J. (1990) · Molecular Endocrinology · doi:10.1210/mend-4-6-800 · Cited by 7
Holst, J. J. (1988) · Advances in metabolic disorders · doi:10.1016/b978-0-12-027311-9.50016-0 · Cited by 5
Mouse Salivary Glands Secrete a Glucagon-Degrading Enzyme, Not Glucagon*
Baldissera, F. G. A., Poulsen, K., & Holst, J. J. (1985) · Endocrinology · doi:10.1210/endo-117-1-84 · Cited by 5
Rushakoff, R. J., Liddle, R. A., Williams, J. A., & Goldfine, I. D. (1990) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-74098-5_7 · Cited by 5
Intestinal Proglucagon-Derived Peptides
Brubaker, P. L., & Drucker, D. J. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-695-9_20 · Cited by 7
Role of endogenous incretin hormones, GLP-1 and GIP, in cardiovascular physiology
Trivedi, K., & Dolinsky, V. W. (2026) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2025-0163 · Cited by 7
GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
Patel, T., Rose, J., Katsurada, K., Yada, T., Koutakis, P., Salomon, J., Patel, K. P., & Alfaidi, M. (2026) · Circulation Research · doi:10.1161/circresaha.126.327683 · Cited by 4
Metabolic and Molecular Amplification of Insulin Secretion
Ferdaoussi, M. (2024) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-031-62232-8_5 · Cited by 4
Incretins and Regulation of Insulin Secretion
Nauck, M. A., & Meier, J. J. (2008) · Springer eBooks · doi:10.1007/978-4-431-75452-7_17 · Cited by 4
The insulin centennial—100 years of milestones in biochemistry
Attie, A., Tang, Q.-Q., & Bornfeldt, K. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100132 · Cited by 4
Furuse, M., Bungo, T., Shimojo, M., Masuda, Y., Saito, N., HASEGAWA, S., & Sugahara, K. (1998) · Japanese poultry science · doi:10.2141/jpsa.35.376 · Cited by 4
The associations of incretin hormone concentration with gestational diabetes mellitus
Саприна, Т. В., Сергеевна, Т. Е., Goncharevich, O. K., Budeeva, S. V., Prokhorenko, T. S., Таширева, Л. А., Мусина, Н. Н., & Дронова, І. (2016) · Diabetes Mellitus · doi:10.14341/dm2004134-37 · Cited by 5
Pharmacological treatment of obesity
Salvador, J., Silva, C., & Santos, E. (2009) · Anales del Sistema Sanitario de Navarra · doi:10.23938/assn.0822 · Cited by 4
López-López, J., Stefano, K. A. D., Velásquez, E., Camacho, P. A., & López-Jaramillo, P. A. (2015) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2015.10.003 · Cited by 8
Kushiyama, A., Kikuchi, T., Tanaka, K., Tahara, T., Takao, T., Onishi, Y., Yoshida, Y., Kawazu, S., & Iwamoto, Y. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i11.230 · Cited by 4
Rehfeld, J. F. (2016) · Endocrinology · doi:10.1007/978-3-319-27318-1_19-1 · Cited by 4
Glucagon and Glucagon‐like Peptide Production and Degradation
Kieffer, T. J., Hussain, M. A., & Habener, J. F. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070208 · Cited by 5
Amylin and Related Proteins: Physiology and Pathophysiology
Cooper, G. J. S. (2001) · Comprehensive physiology · doi:10.1002/cphy.cp070210 · Cited by 7
Biochemistry and Biology of Vasopressin, Oxytocin, and Their Corresponding Neurophysins
Richter, D. (1987) · Elsevier eBooks · doi:10.1016/b978-0-12-304208-8.50007-8 · Cited by 4
Incretin Mimetics in Cancer and Cardiovascular Disease
Leong, D. P., Gong, S., Sattar, N. A., Narayan, V., Reizine, N. M., Gerstein, H. C., & Vellky, J. E. (2026) · JACC CardioOncology · doi:10.1016/j.jaccao.2025.12.003 · Cited by 3
Li, M., Fang, J., Qi, G., Guo, S., Xu, T., Lu, Y., Yuan, Q., Wang, J., Zhu, S., Shen, J., et al. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6c00077 · Cited by 3
Alogliptin + metformin combination for the treatment of type 2 diabetes mellitus
Neumiller, J. J., & Holland, D. Q. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1110484 · Cited by 3
“[5,6] GLP-1 was later identified as another hormone with insulinotropic actions.[7] The glucoregulatory effects of GLP-1 result from several mechanisms.”
BackgroundLópez-Jaramillo, P. A., Velandia, C., Castillo, G., Sánchez, T. E. A., & Álvarez, J. (2013) · Revista Colombiana de Cardiología · doi:10.1016/s0120-5633(13)70072-x · Cited by 4
“Posteriormente se describió (50) una segunda incretina, denominada péptido semejante al glucagón tipo 1 (GLP-1), que es la sustancia que tiene un mayor rol en el efecto incretina (51).”
BackgroundA novel element regulates expression of the proximal human proglucagon promoter in islet cells
Tsai, B., Yue, S., & Irwin, D. M. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.01.012 · Cited by 4
Blatt, A., Shiloah, E., Mincha, S., Bloch, O., & Rapoport, M. J. (2013) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000011 · Cited by 3
Metadata
- Authors
- Bell, G. I., Santerre, R. F., & Mullenbach, G. T.
- Affiliations
- Eli Lilly (United States) (US)
- Venue
- Nature
- Published
- 1983-04
- Volume
- 302
- Issue
- 5910
- Pages
- 716-718
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2061274996
- Cited by
- 649
- References
- 35
- Citations by year
- 2026: 22 · 2025: 22 · 2024: 22 · 2023: 9 · 2022: 16 · 2021: 20 · 2020: 8 · 2019: 16 · 2018: 16 · 2017: 8 · 2016: 18 · 2015: 13 · 2014: 21 · 2013: 12 · 2012: 9
- FWCI
- 41.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proglucagon, glucagon, hamster, pancreatic A cells, cDNA sequence, precursor processing
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Fishes, Glucagon, Cricetinae, Molecular Weight, Protein Precursors, RNA, Messenger, Species Specificity, Proglucagon
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.